WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 2, 2006--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, including diabetic peripheral neuropathy, announced today that it has signed a mutually exclusive agreement with Parlex USA, Inc., a division of Johnson Electric, for the manufacturing of biosensors sold by NeuroMetrix and used by physicians to diagnose neuropathies.
